Cargando…

Cortex-wide topography of 1/f-exponent in Parkinson’s disease

Parkinson’s disease (PD) is a progressive and debilitating brain disorder. Besides the characteristic movement-related symptoms, the disease also causes decline in sensory and cognitive processing. The extent of symptoms and brain-wide projections of neuromodulators such as dopamine suggest that man...

Descripción completa

Detalles Bibliográficos
Autores principales: Helson, Pascal, Lundqvist, Daniel, Svenningsson, Per, Vinding, Mikkel C., Kumar, Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338503/
https://www.ncbi.nlm.nih.gov/pubmed/37438362
http://dx.doi.org/10.1038/s41531-023-00553-6
_version_ 1785071642311917568
author Helson, Pascal
Lundqvist, Daniel
Svenningsson, Per
Vinding, Mikkel C.
Kumar, Arvind
author_facet Helson, Pascal
Lundqvist, Daniel
Svenningsson, Per
Vinding, Mikkel C.
Kumar, Arvind
author_sort Helson, Pascal
collection PubMed
description Parkinson’s disease (PD) is a progressive and debilitating brain disorder. Besides the characteristic movement-related symptoms, the disease also causes decline in sensory and cognitive processing. The extent of symptoms and brain-wide projections of neuromodulators such as dopamine suggest that many brain regions are simultaneously affected in PD. To characterise brain-wide disease-related changes in neuronal function, we analysed resting state magnetoencephalogram (MEG) from two groups: PD patients and healthy controls. Besides standard spectral analysis, we quantified the aperiodic components (κ, λ) of the neural activity by fitting a power law κ/f(λ) – f is the frequency, κ and λ are the fitting parameters—to the MEG power spectrum and studied its relationship with age and Unified Parkinson’s Disease Rating Scale (UPDRS). Consistent with previous results, the most significant spectral changes were observed in the high theta/low-alpha band (7–10 Hz) in all brain regions. Furthermore, analysis of the aperiodic part of the spectrum showed that in all but frontal regions λ was significantly larger in PD patients than in control subjects. Our results indicate that PD is associated with significant changes in aperiodic activity across the whole neocortex. Surprisingly, even early sensory areas showed a significantly larger λ in patients than in healthy controls. Moreover, λ was not affected by the Levodopa medication. Finally, λ was positively correlated with patient age but not with UPDRS-III. Because λ is closely associated with excitation-inhibition balance, our results propose new hypotheses about neural correlates of PD in cortical networks.
format Online
Article
Text
id pubmed-10338503
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103385032023-07-14 Cortex-wide topography of 1/f-exponent in Parkinson’s disease Helson, Pascal Lundqvist, Daniel Svenningsson, Per Vinding, Mikkel C. Kumar, Arvind NPJ Parkinsons Dis Article Parkinson’s disease (PD) is a progressive and debilitating brain disorder. Besides the characteristic movement-related symptoms, the disease also causes decline in sensory and cognitive processing. The extent of symptoms and brain-wide projections of neuromodulators such as dopamine suggest that many brain regions are simultaneously affected in PD. To characterise brain-wide disease-related changes in neuronal function, we analysed resting state magnetoencephalogram (MEG) from two groups: PD patients and healthy controls. Besides standard spectral analysis, we quantified the aperiodic components (κ, λ) of the neural activity by fitting a power law κ/f(λ) – f is the frequency, κ and λ are the fitting parameters—to the MEG power spectrum and studied its relationship with age and Unified Parkinson’s Disease Rating Scale (UPDRS). Consistent with previous results, the most significant spectral changes were observed in the high theta/low-alpha band (7–10 Hz) in all brain regions. Furthermore, analysis of the aperiodic part of the spectrum showed that in all but frontal regions λ was significantly larger in PD patients than in control subjects. Our results indicate that PD is associated with significant changes in aperiodic activity across the whole neocortex. Surprisingly, even early sensory areas showed a significantly larger λ in patients than in healthy controls. Moreover, λ was not affected by the Levodopa medication. Finally, λ was positively correlated with patient age but not with UPDRS-III. Because λ is closely associated with excitation-inhibition balance, our results propose new hypotheses about neural correlates of PD in cortical networks. Nature Publishing Group UK 2023-07-13 /pmc/articles/PMC10338503/ /pubmed/37438362 http://dx.doi.org/10.1038/s41531-023-00553-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Helson, Pascal
Lundqvist, Daniel
Svenningsson, Per
Vinding, Mikkel C.
Kumar, Arvind
Cortex-wide topography of 1/f-exponent in Parkinson’s disease
title Cortex-wide topography of 1/f-exponent in Parkinson’s disease
title_full Cortex-wide topography of 1/f-exponent in Parkinson’s disease
title_fullStr Cortex-wide topography of 1/f-exponent in Parkinson’s disease
title_full_unstemmed Cortex-wide topography of 1/f-exponent in Parkinson’s disease
title_short Cortex-wide topography of 1/f-exponent in Parkinson’s disease
title_sort cortex-wide topography of 1/f-exponent in parkinson’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338503/
https://www.ncbi.nlm.nih.gov/pubmed/37438362
http://dx.doi.org/10.1038/s41531-023-00553-6
work_keys_str_mv AT helsonpascal cortexwidetopographyof1fexponentinparkinsonsdisease
AT lundqvistdaniel cortexwidetopographyof1fexponentinparkinsonsdisease
AT svenningssonper cortexwidetopographyof1fexponentinparkinsonsdisease
AT vindingmikkelc cortexwidetopographyof1fexponentinparkinsonsdisease
AT kumararvind cortexwidetopographyof1fexponentinparkinsonsdisease